These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 28863773)

  • 21. microRNA-148a-3p inhibited the proliferation and epithelial-mesenchymal transition progression of non-small-cell lung cancer via modulating Ras/MAPK/Erk signaling.
    Xie Q; Yu Z; Lu Y; Fan J; Ni Y; Ma L
    J Cell Physiol; 2019 Aug; 234(8):12786-12799. PubMed ID: 30536836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-148a-3p represses proliferation and EMT by establishing regulatory circuits between ERBB3/AKT2/c-myc and DNMT1 in bladder cancer.
    Wang X; Liang Z; Xu X; Li J; Zhu Y; Meng S; Li S; Wang S; Xie B; Ji A; Liu B; Zheng X; Xie L
    Cell Death Dis; 2016 Dec; 7(12):e2503. PubMed ID: 27906180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Site-specific associations between miRNA expression and survival in colorectal cancer cases.
    Slattery ML; Herrick JS; Pellatt DF; Mullany LE; Stevens JR; Wolff E; Hoffman MD; Wolff RK; Samowitz W
    Oncotarget; 2016 Sep; 7(37):60193-60205. PubMed ID: 27517623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.
    To KK; Tong CW; Wu M; Cho WC
    World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression.
    Dong P; Ihira K; Xiong Y; Watari H; Hanley SJ; Yamada T; Hosaka M; Kudo M; Yue J; Sakuragi N
    Oncotarget; 2016 Apr; 7(15):20260-70. PubMed ID: 26934121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-148a-3p inhibits cancer progression and is a novel screening biomarker for gastric cancer.
    Bao C; Guo L
    J Clin Lab Anal; 2020 Oct; 34(10):e23454. PubMed ID: 32785967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening and preliminary validation of miRNAs with the regulation of hTERT in colorectal cancer.
    Qin YZ; Xie XC; Liu HZ; Lai H; Qiu H; Ge LY
    Oncol Rep; 2015 Jun; 33(6):2728-36. PubMed ID: 25845814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of Differentially Expressed MicroRNAs involved in the Pathogenesis of Colorectal Cancer.
    Feng H; Xu M; Zhang Y; Han B; Wang J; Sun P
    Clin Lab; 2018 May; 64(5):797-804. PubMed ID: 29739047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA profiling differentiates colorectal cancer according to KRAS status.
    Mosakhani N; Sarhadi VK; Borze I; Karjalainen-Lindsberg ML; Sundström J; Ristamäki R; Osterlund P; Knuutila S
    Genes Chromosomes Cancer; 2012 Jan; 51(1):1-9. PubMed ID: 21922590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-4728-3p Functions as a Tumor Suppressor in Ulcerative Colitis-associated Colorectal Neoplasia Through Regulation of Focal Adhesion Signaling.
    Pekow J; Hutchison AL; Meckel K; Harrington K; Deng Z; Talasila N; Rubin DT; Hanauer SB; Hurst R; Umanskiy K; Fichera A; Hart J; Dinner AR; Bissonnette M
    Inflamm Bowel Dis; 2017 Aug; 23(8):1328-1337. PubMed ID: 28594651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-363-3p inhibits the epithelial-to-mesenchymal transition and suppresses metastasis in colorectal cancer by targeting Sox4.
    Hu F; Min J; Cao X; Liu L; Ge Z; Hu J; Li X
    Biochem Biophys Res Commun; 2016 May; 474(1):35-42. PubMed ID: 27084453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Down-regulation of miR-24-3p in colorectal cancer is associated with malignant behavior.
    Gao Y; Liu Y; Du L; Li J; Qu A; Zhang X; Wang L; Wang C
    Med Oncol; 2015 Jan; 32(1):362. PubMed ID: 25502080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression Analysis of Previously Verified Fecal and Plasma Dow-regulated MicroRNAs (miR-4478, 1295-3p, 142-3p and 26a-5p), in FFPE Tissue Samples of CRC Patients.
    Ghanbari R; Rezasoltani S; Hashemi J; Mohamadkhani A; Tahmasebifar A; Arefian E; Mobarra N; Asadi J; Nazemalhosseini Mojarad E; Yazdani Y; Knuutila S; Malekzadeh R
    Arch Iran Med; 2017 Feb; 20(2):92-95. PubMed ID: 28193082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relevance of MicroRNAs as Potential Diagnostic and Prognostic Markers in Colorectal Cancer.
    Hibner G; Kimsa-Furdzik M; Francuz T
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30262723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased expression of fecal miR-4478 and miR-1295b-3p in early-stage colorectal cancer.
    Ghanbari R; Mosakhani N; Asadi J; Nouraee N; Mowla SJ; Poustchi H; Malekzadeh R; Knuutila S
    Cancer Biomark; 2015; 15(2):189-95. PubMed ID: 25519020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of selected microRNAs in pancreatic ductal adenocarcinoma: is there a relation to tumor morphology, progression and patient's outcome?
    Szabo A; Gurlich R; Liberko M; Soumarova R; Vernerova Z; Mandys V; Popov A
    Neoplasma; 2020 Sep; 67(5):1170-1181. PubMed ID: 32567937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RNA-Sequencing Based microRNA Expression Signature of Colorectal Cancer: The Impact of Oncogenic Targets Regulated by
    Hozaka Y; Kita Y; Yasudome R; Tanaka T; Wada M; Idichi T; Tanabe K; Asai S; Moriya S; Toda H; Mori S; Kurahara H; Ohtsuka T; Seki N
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA 483-3p overexpression unleashes invasive growth of metastatic colorectal cancer via NDRG1 downregulation and ensuing activation of the ERBB3/AKT axis.
    Candiello E; Reato G; Verginelli F; Gambardella G; D Ambrosio A; Calandra N; Orzan F; Iuliano A; Albano R; Sassi F; Luraghi P; Comoglio PM; Bertotti A; Trusolino L; Boccaccio C
    Mol Oncol; 2023 Jul; 17(7):1280-1301. PubMed ID: 36862005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fecal microRNA profile in patients with colorectal carcinoma before and after curative surgery.
    Rotelli MT; Di Lena M; Cavallini A; Lippolis C; Bonfrate L; Chetta N; Portincasa P; Altomare DF
    Int J Colorectal Dis; 2015 Jul; 30(7):891-8. PubMed ID: 25989926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.